Skip to content

Ameliorating Effects and Autonomic Mechanisms of Transcutaneous Electrical Acustimulation on Motion Sickness: a Randomized Controlled Trial.

Ameliorating Effects and Autonomic Mechanisms of Transcutaneous Electrical Acustimulation on Motion Sickness

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003552
Enrollment
Unknown
Registered
2020-08-06
Start date
2020-08-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motion sickness

Interventions

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-65 years; 2)Subjects with motion sickness; 3) Willing to sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1) Autoimmune diseases affecting gastrointestinal motility such as scleroderma, dermatomyositis, etc.; 2) Smoking >= 5 cigarettes a day; 3) Severe vestibular dysfunction, cardiovascular, respiratory, liver and kidney disease, hematopoietic system disorders, etc.; 4) History of gastrointestinal surgery; 5) Drinking alcohol during the study period (equivalent to >= 40g/ day for men); 6) Allergic to skin preparation or medical electrodes, 7) Familiar with acupuncture, acupoints, or meridian.

Design outcomes

Primary

MeasureTime frame
Total tolerable rotation time;Motion Sickness Symptom Ratings;

Secondary

MeasureTime frame
physiological measurements;Gastric slow waves;heart rate variability;

Countries

China

Contacts

Public ContactWeifen Xie

Shanghai Changzheng Hospital

weifenxie@medmail.com+86 13701682806

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026